Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs

被引:17
作者
Appel, S
Bringmann, A
Grünebach, F
Week, MM
Bauer, J
Brossart, P
机构
[1] Univ Tubingen, Dept Hematol Oncol & Immunol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany
[3] Univ Bergen, Dept Biomed, Bergen, Norway
关键词
D O I
10.1182/blood-2005-06-2480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dendritic cells (DCs) are recognized as the most potent antigen-presenting cells of the immune system with the unique ability to initiate and maintain primary immune responses. In order to better characterize the functional and phenotypic features of DCs, a subtractive cDNA library to identify differentially expressed genes in monocyte-derived DCs (MDCs) was constructed. Using this approach, we found that the epithelial transcription factor ESE-3, which was previously shown to be exclusively expressed in cells of epithelial origin, is differentially expressed in MDCs. This was further confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot analyses. The expression of ESE-3 is up-regulated upon maturation of MDCs and inhibited by treating the cells with IL-10 or IFN-gamma. Knockdown experiments using siRNA suggest that ESE-3 plays an important role during MDC development. Our results might help to improve the phenotypic characterization of DCs and lead to a better understanding of the cellular mechanisms involved in antigen presentation and T-cell stimulation.
引用
收藏
页码:3265 / 3270
页数:6
相关论文
共 29 条
[1]  
Allavena P, 1997, ADV EXP MED BIOL, V417, P323
[2]   Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells [J].
Appel, S ;
Boehmler, AM ;
Grünebach, F ;
Müller, MR ;
Rupf, A ;
Weck, MM ;
Hartmann, U ;
Reichardt, VL ;
Kanz, L ;
Brümmendorf, TH ;
Brossart, P .
BLOOD, 2004, 103 (02) :538-544
[3]   Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-κB and Akt signaling pathways [J].
Appel, S ;
Rupf, A ;
Weck, MM ;
Schoor, O ;
Brümmendorf, TH ;
Weinschenk, T ;
Grünebach, F ;
Brossart, P .
CLINICAL CANCER RESEARCH, 2005, 11 (05) :1928-1940
[4]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Molecular cloning and expression of Ehf, a new member of the ets transcription factor oncoprotein gene family [J].
Bochert, MA ;
Kleinbaum, LA ;
Sun, LY ;
Burton, FH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (01) :176-181
[7]   INCREASED T-CELL APOPTOSIS AND TERMINAL B-CELL DIFFERENTIATION-INDUCED BY INACTIVATION OF THE ETS-1 PROTOONCOGENE [J].
BORIES, JC ;
WILLERFORD, DM ;
GREVIN, D ;
DAVIDSON, L ;
CAMUS, A ;
MARTIN, P ;
STEHELIN, D ;
ALT, FW .
NATURE, 1995, 377 (6550) :635-638
[8]   Dendritic cells in cancer vaccines [J].
Brossart, P ;
Wirths, S ;
Brugger, W ;
Kanz, L .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (11) :1247-1255
[9]   EXPRESSION OF RELB IS REQUIRED FOR THE DEVELOPMENT OF THYMIC MEDULLA AND DENDRITIC CELLS [J].
BURKLY, L ;
HESSION, C ;
OGATA, L ;
REILLY, C ;
MARCONI, LA ;
OLSON, D ;
TIZARD, R ;
CATE, R ;
LO, D .
NATURE, 1995, 373 (6514) :531-536
[10]   IL-6 switches the differentiation of monocytes from dendritic cells to macrophages [J].
Chomarat, P ;
Banchereau, J ;
Davoust, J ;
Palucka, AK .
NATURE IMMUNOLOGY, 2000, 1 (06) :510-514